naltrexone associated_with auditory

Subject: naltrexone
Relation: associated_with
Object: auditory
p-value: —

Evidence from: primary | all sources

Evidence (1 sources)

Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies. (2021) PMID:32064741 primary

Naltrexone, an opioid antagonist approved by the U.S. Food and Drug Administration for the treatment of AUD

confidence: 0.96